| SHEL | 8.02% | 30.92 | -0.13% | 134,195 | |
| AZN | 7.86% | 10,450.0 | -1.66% | 33,047 | |
| HSBA | 7.28% | 910.50 | -1.03% | 393,854 | |
| ULVR | 5.24% | 51.86 | -1.33% | 53,742 | |
| REL | 3.38% | 3,985.00 | -0.18% | 41,299 | |
| BP | 3.28% | 402.05 | +3.42% | 356,092 | |
| RR | 2.98% | 1.820 | -2.67% | 187,868 | |
| BATS | 2.93% | 3,788.0 | +2.19% | 43,538 | |
| GSK | 2.73% | 1,408.50 | -3.16% | 88,322 | |
| LSEG | 2.66% | 10,740.0 | -1.29% | 10,976 |
Sygnia Itrix FTSE 100 ETF is an exchange traded fund launched by Sygnia Itrix (RF) Proprietary Limited. The fund is managed by Bank of New York Mellon Capital Management Corporation. It invests in the public equity markets of the United Kingdom. The fund invests in stocks of companies operating across diversified sectors. It invests in stocks of large-cap companies. The fund seeks to replicate the performance of the FTSE 100 Index, by investing in stocks of companies as per their weightings in the index. It was formerly known as db x-trackers FTSE 100 Index ETF. Sygnia Itrix FTSE 100 ETF was formed September 19, 2005 and is domiciled in South Africa.